Papers: 10.1371/journal.pone.0042701
https://doi.org/10.1371/journal.pone.0042701
A Safety Review and Meta-Analyses of Bevacizumab and Ranibizumab: Off-Label versus Goldstandard
Cited by: 121
Author(s): Christine Schmucker, Christoph Ehlken, Hansjuergen Agostini, Gerd Antes, Gerta Ruecker, Monika Lelgemann, Yoon K. Loke
Published: about 13 years ago
Software Mentions 1
Likely Science (50)